Showing results (431-440 of 786) with videos related to

Sort By:
Pageof 79
In Silico Pharmacology|November 10, 2025
Inhibitory potential of Malabaricone C and Quercetagetin against aberrantly expressed Maternal Embryonic Leucine Zipper Kinase using integrated virtual screening, molecular dynamics and MMGBSA approachNandan Dixit, Harsha Motwani, Maulikkumar Patel, et al.
In Silico Pharmacology|November 10, 2025
Structure based in-silico study for the design of novel Curcumin analogs against Farnesoid-X-receptor (FXR) receptor as hepatoprotective agentsAneri Joshi, Vivek K Vyas, Sriram Seshadri
In Silico Pharmacology|November 10, 2025
Terpenoids modulation of the IFI16-AIM2 interaction for enhanced immune response in lung squamous cell carcinoma and AIM2-dysregulated diseasesAwais Ali, Abdulaziz Alamri, Wassef Ullah, et al.
In Silico Pharmacology|November 10, 2025
Genomic insights and immunoinformatics-driven design of a multi-epitope subunit vaccine candidate against Shamonda virusElijah Kolawole Oladipo, Stephen Feranmi Adeyemo, James Akinwumi Ogunniran, et al.
In Silico Pharmacology|October 30, 2025
In silico approaches to identify therapeutic drug targets against COVID-19: a detailed review with a case studyTanmayee Basu, Atul Kumar Upadhyay
In Silico Pharmacology|August 12, 2025
Exploring lichen-derived compounds as potential anti-cervical cancer agents: an DFT and MD simulation analysisBalasubramanian Murugesan, Bharath Somasundram, Gopinath Samykannu, et al.
In Silico Pharmacology|September 8, 2025
In silico framework about prediction of collagen-derived matrikine generation and its ligand function binding to integrin [Formula: see text] for malignancy of colon cancerYun Shin, Jin-Ku Lee
In Silico Pharmacology|September 19, 2025
In-silico identification of COX-2 inhibitory phytochemicals from traditional medicinal plants: molecular docking, dynamics, and safety predictionsFaranak Abdollahi, Farzin Hadizadeh, Sadegh Farhadian, et al.
In Silico Pharmacology|July 24, 2025
Pharmacophoric analogs of Savolitinib reveal promising inhibitors of the c-MET receptor tyrosine kinase for drug discovery: in silico investigationLateef Adegboyega Sulaimon, Hameedah Ayanfunke Bamiji, Mercy Eshiet Akpekong, et al.
In Silico Pharmacology|July 24, 2025
Aryl benzoyl hydrazide derivatives as potent inhibitors of the NS2B-NS3 protease and RNA-dependent RNA polymerase of the zika virusR P Yadav, N R Jena
Pageof 79